Rheumatrex

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:activities gptkb:fragrance
inhibits dihydrofolate reductase
gptkbp:approves 1953
gptkbp:brand gptkb:Trexall
gptkb:Otrexup
gptkb:Rasuvo
gptkbp:category gptkb:X
not recommended
gptkbp:contraindication alcohol consumption
pregnancy
breastfeeding
gptkbp:dosage_form injection
oral tablet
gptkbp:education avoid alcohol
stay hydrated
avoid live vaccines
report signs of infection
gptkbp:excretion urine
gptkbp:formulation gptkb:tablet
injection solution
https://www.w3.org/2000/01/rdf-schema#label Rheumatrex
gptkbp:indication gptkb:healthcare_organization
gptkb:non-Hodgkin_lymphoma
gptkb:choriocarcinoma
gestational trophoblastic disease
severe psoriasis
gptkbp:ingredients gptkb:methotrexate
C20 H22 N8 O5
gptkbp:interacts_with live vaccines
penicillins
NSAI Ds
sulfonamides
gptkbp:is_atype_of L01 B A01
gptkbp:is_monitored_by liver function tests
complete blood count
renal function tests
gptkbp:is_used_for treatment of psoriasis
treatment of rheumatoid arthritis
treatment of certain types of cancer
gptkbp:legal_issue prescription only
gptkbp:lifespan 3 to 10 hours
gptkbp:manager oral
injection
gptkbp:manufacturer various pharmaceutical companies
gptkbp:metabolism hepatic
gptkbp:rounds renal
gptkbp:side_effect fatigue
nausea
liver toxicity
mouth sores
gptkbp:storage room temperature
protected from light
gptkbp:type_of 59-05-2
gptkbp:bfsParent gptkb:methotrexate
gptkbp:bfsLayer 4